Emergent BioSolutions Inc. (NYSE:EBS) Q4 2023 Earnings Call Transcript

Emergent BioSolutions Inc. (NYSE:EBS) Q4 2023 Earnings Call Transcript March 6, 2024

Emergent BioSolutions Inc. misses on earnings expectations. Reported EPS is $-0.77 EPS, expectations were $-0.33. Emergent BioSolutions Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).

Operator: Good afternoon, everyone. I’m the operator for today’s call. Thank you for joining today as Emergent discusses their Operation and Financial...